Madeleine Henriquez, PA-C

NPI: 1487025797
Total Payments
$13,978
2022 Payments
$41.73
Companies
4
Transactions
32
Medicare Patients
344
Medicare Billing
$17,030

Payment Breakdown by Category

Other$10,460 (74.8%)
Consulting$2,062 (14.8%)
Travel$686.85 (4.9%)
Food & Beverage$670.35 (4.8%)
Education$99.00 (0.7%)

Payments by Nature

Nature of Payment Amount Transactions Share
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $10,460 10 74.8%
Consulting Fee $2,062 2 14.8%
Travel and Lodging $686.85 6 4.9%
Food and Beverage $670.35 13 4.8%
Education $99.00 1 0.7%

Top Paying Companies

Company Total Records Latest Year
Incyte Corporation $13,216 25 $0 (2021)
Celgene Corporation $561.75 1 $0 (2021)
Janssen Biotech, Inc. $182.27 5 $0 (2022)
Adaptive Biotechnologies Corporation $17.68 1 $0 (2021)

Payment History by Year

Year Amount Transactions Top Company
2022 $41.73 2 Janssen Biotech, Inc. ($41.73)
2021 $13,936 30 Incyte Corporation ($13,216)

All Payment Transactions

32 individual payment records from CMS Open Payments — Page 1 of 2

Date Company Product Nature Form Amount Type
07/26/2022 Janssen Biotech, Inc. IMBRUVICA (Drug) Food and Beverage In-kind items and services $23.22 General
Category: Oncology
06/14/2022 Janssen Biotech, Inc. IMBRUVICA (Drug) Food and Beverage In-kind items and services $18.51 General
Category: Oncology
12/23/2021 Incyte Corporation Consulting Fee Cash or cash equivalent $1,500.00 General
12/14/2021 Incyte Corporation JAKAFI (Drug) Food and Beverage Cash or cash equivalent $24.55 General
Category: Hematology/Oncology
12/08/2021 Adaptive Biotechnologies Corporation clonoSEQ (Device) Food and Beverage In-kind items and services $17.68 General
Category: B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA
11/22/2021 Incyte Corporation JAKAFI (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $570.00 General
Category: Hematology/Oncology
11/18/2021 Janssen Biotech, Inc. IMBRUVICA (Drug) Education In-kind items and services $99.00 General
Category: Oncology
11/11/2021 Janssen Biotech, Inc. IMBRUVICA (Drug) Food and Beverage In-kind items and services $27.02 General
Category: Oncology
11/04/2021 Incyte Corporation JAKAFI (Drug) Food and Beverage Cash or cash equivalent $24.62 General
Category: Hematology/Oncology
10/20/2021 Incyte Corporation JAKAFI (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $1,140.00 General
Category: Hematology/Oncology
10/07/2021 Incyte Corporation JAKAFI (Drug) Food and Beverage Cash or cash equivalent $114.84 General
Category: Hematology/Oncology
10/01/2021 Incyte Corporation JAKAFI (Drug) Travel and Lodging Cash or cash equivalent $20.16 General
Category: Hematology/Oncology
08/11/2021 Incyte Corporation JAKAFI (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $1,140.00 General
Category: Hematology/Oncology
08/05/2021 Incyte Corporation JAKAFI (Drug) Food and Beverage Cash or cash equivalent $125.00 General
Category: Hematology/Oncology
08/01/2021 Incyte Corporation JAKAFI (Drug) Travel and Lodging Cash or cash equivalent $22.40 General
Category: Hematology/Oncology
07/30/2021 Incyte Corporation JAKAFI (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $1,520.00 General
Category: Hematology/Oncology
07/30/2021 Incyte Corporation JAKAFI (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $580.00 General
Category: Hematology/Oncology
07/01/2021 Incyte Corporation JAKAFI (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $380.00 General
Category: Hematology/Oncology
06/16/2021 Incyte Corporation JAKAFI (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $1,520.00 General
Category: Hematology/Oncology
06/15/2021 Incyte Corporation JAKAFI (Drug) Food and Beverage Cash or cash equivalent $15.15 General
Category: Hematology/Oncology
06/08/2021 Incyte Corporation JAKAFI (Drug) Travel and Lodging Cash or cash equivalent $198.77 General
Category: Hematology/Oncology
06/08/2021 Incyte Corporation JAKAFI (Drug) Food and Beverage Cash or cash equivalent $97.72 General
Category: Hematology/Oncology
06/01/2021 Incyte Corporation JAKAFI (Drug) Travel and Lodging Cash or cash equivalent $188.16 General
Category: Hematology/Oncology
05/28/2021 Celgene Corporation REBLOZYL (Biological) Consulting Fee Cash or cash equivalent $561.75 General
Category: Hematology
05/20/2021 Incyte Corporation JAKAFI (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $1,520.00 General
Category: Hematology/Oncology

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2021 7 222 285 $62,955 $11,480
2020 4 122 134 $45,674 $5,549
Total Patients
344
Total Services
419
Medicare Billing
$17,030
Procedure Codes
11

All Medicare Procedures & Services

11 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99213 Established patient outpatient visit, total time 20-29 minutes Facility 2021 60 80 $12,600 $3,697 29.3%
99212 Established patient outpatient visit, total time 10-19 minutes Facility 2021 71 97 $10,927 $2,453 22.5%
99214 Established patient outpatient visit, total time 30-39 minutes Facility 2021 25 31 $7,538 $2,103 27.9%
38222 Diagnostic aspirations and biopsies of bone marrow Facility 2021 27 27 $19,015 $1,470 7.7%
99441 Physician telephone patient service, 5-10 minutes of medical discussion Facility 2021 16 27 $3,037 $632.25 20.8%
99442 Physician telephone patient service, 11-20 minutes of medical discussion Facility 2021 12 12 $1,902 $583.22 30.7%
38220 Aspiration of bone marrow Facility 2021 11 11 $7,936 $540.43 6.8%
99213 Established patient office or other outpatient visit, typically 15 minutes Facility 2020 57 67 $10,224 $2,154 21.1%
38222 Bone marrow biopsy and aspiration Facility 2020 30 30 $20,418 $1,510 7.4%
99214 Established patient office or other outpatient, visit typically 25 minutes Facility 2020 22 23 $5,458 $1,275 23.4%
38220 Diagnostic bone marrow aspiration Facility 2020 13 14 $9,574 $609.51 6.4%

About Madeleine Henriquez, PA-C

Madeleine Henriquez, PA-C is a Physician Assistant healthcare provider based in Houston, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/13/2015. The National Provider Identifier (NPI) number assigned to this provider is 1487025797.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Madeleine Henriquez, PA-C has received a total of $13,978 in payments from pharmaceutical and medical device companies, with $41.73 received in 2022. These payments were reported across 32 transactions from 4 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($10,460).

As a Medicare-enrolled provider, Henriquez has provided services to 344 Medicare beneficiaries, totaling 419 services with total Medicare billing of $17,030. Data is available for 2 years (2020–2021), covering 11 distinct procedure/service records.

Practice Information

  • Specialty Physician Assistant
  • Location Houston, TX
  • Active Since 10/13/2015
  • Last Updated 09/10/2019
  • Taxonomy Code 363A00000X
  • Entity Type Individual
  • NPI Number 1487025797

Products in Payments

  • JAKAFI (Drug) $11,716
  • REBLOZYL (Biological) $561.75
  • IMBRUVICA (Drug) $167.75
  • clonoSEQ (Device) $17.68
  • DARZALEX (Biological) $14.52

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Physician Assistant Doctors in Houston